Keros Therapeutics Director Jean Jacques Bienaime buys USD 10,610 in common shares

PUBT · 22h ago
Keros Therapeutics Director Jean Jacques Bienaime buys USD 10,610 in common shares
  • Keros Therapeutics director Jean Jacques Bienaime bought 1,000 common shares at a weighted-average price of USD 10.61.
  • His direct holding rose to 18,592 shares following the purchase.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Keros Therapeutics Inc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001221590-26-000023), on July 17, 2026, and is solely responsible for the information contained therein.